{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:48Z","timestamp":1791232368506,"version":"4.1.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41574-024-00985-x","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T11:09:21Z","timestamp":1714561761000},"page":"487-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-7304","authenticated-orcid":false,"given":"Cihan","family":"Atila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-4685","authenticated-orcid":false,"given":"Julie","family":"Refardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-0965","authenticated-orcid":false,"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","volume":"5","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain, M. et al. Diabetes insipidus. Nat. Rev. Dis. Prim. 5, 54 (2019). This review outlines diagnosis and treatment of diabetes insipidus (arginine vasopressin deficiency and arginine vasopressin resistance) and primary polydipsia.","journal-title":"Nat. Rev. Dis. Prim."},{"key":"985_CR2","volume":"13","author":"CM Mutter","year":"2021","unstructured":"Mutter, C. M. et al. Diabetes insipidus: pathogenesis, diagnosis, and clinical management. Cureus 13, e13523 (2021).","journal-title":"Cureus"},{"key":"985_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/cen.13578","volume":"88","author":"M Prentice","year":"2018","unstructured":"Prentice, M. Time for change: renaming diabetes insipidus to improve patient safety. Clin. Endocrinol. 88, 625\u2013626 (2018).","journal-title":"Clin. Endocrinol."},{"key":"985_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S2213-8587(22)00219-4","volume":"10","author":"C Atila","year":"2022","unstructured":"Atila, C. et al. Central diabetes insipidus from a patient\u2019s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes Endocrinol. 10, 700\u2013709 (2022). A study presenting data on psychological comorbidities and treatment adverse effects from a web-based survey in >1,000 patients with arginine vasopressin deficiency.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgac547","volume":"108","author":"H Arima","year":"2022","unstructured":"Arima, H. et al. Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus. J. Clin. Endocrinol. Metab. 108, 1\u20133 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1803760","volume":"379","author":"W Fenske","year":"2018","unstructured":"Fenske, W. et al. A copeptin-based approach in the diagnosis of diabetes insipidus. N. Engl. J. Med. 379, 428\u2013439 (2018). A multicentre diagnostic study that shows the superiority of the hypertonic saline-stimulated copeptin test compared with the indirect water deprivation test in the differential diagnosis of the polyuria\u2013polydipsia syndrome.","journal-title":"N. Engl. J. Med."},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(19)31255-3","volume":"394","author":"B Winzeler","year":"2019","unstructured":"Winzeler, B. et al. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet 394, 587\u2013595 (2019). A diagnostic study showing a high diagnostic accuracy of the arginine-stimulated copeptin test in the differential diagnosis of the polyuria\u2013polydipsia syndrome.","journal-title":"Lancet"},{"key":"985_CR8","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa2306263","volume":"389","author":"J Refardt","year":"2023","unstructured":"Refardt, J. et al. Arginine or hypertonic saline-stimulated copeptin to diagnose AVP deficiency. N. Engl. J. Med. 389, 1877\u20131887 (2023). A head-to-head comparison of hypertonic saline versus arginine-stimulated copeptin tests that demonstrates the superiority of the hypertonic saline test in the differential diagnosis of the polyuria\u2013polydipsia syndrome.","journal-title":"N. Engl. J. Med."},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S2213-8587(23)00120-1","volume":"11","author":"C Atila","year":"2023","unstructured":"Atila, C. et al. Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case\u2013control study with nested, randomised, double-blind, placebo-controlled crossover trial. Lancet Diabetes Endocrinol. 11, 454\u2013464 (2023). A study that provides evidence for an oxytocin deficiency in patients with arginine vasopressin deficiency.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/B:PITU.0000044633.52516.e1","volume":"7","author":"J Lindholm","year":"2004","unstructured":"Lindholm, J. Diabetes insipidus: historical aspects. Pituitary 7, 33\u201338 (2004).","journal-title":"Pituitary"},{"key":"985_CR11","first-page":"333","volume":"33","author":"GL Robertson","year":"1976","unstructured":"Robertson, G. L. The regulation of vasopressin function in health and disease. Recent Prog. Horm. Res. 33, 333\u2013385 (1976).","journal-title":"Recent Prog. Horm. Res."},{"key":"985_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7326\/0003-4819-73-5-721","volume":"73","author":"M Miller","year":"1970","unstructured":"Miller, M., Dalakos, T., Moses, A. M., Fellerman, H. & Streeten, D. H. Recognition of partial defects in antidiuretic hormone secretion. Ann. Intern. Med. 73, 721\u2013729 (1970).","journal-title":"Ann. Intern. Med."},{"key":"985_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrneph.2015.89","volume":"11","author":"D Bockenhauer","year":"2015","unstructured":"Bockenhauer, D. & Bichet, D. G. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat. Rev. Nephrol. 11, 576\u2013588 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"985_CR14","first-page":"w14514","volume":"147","author":"C Sailer","year":"2017","unstructured":"Sailer, C., Winzeler, B. & Christ-Crain, M. Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy. Swiss Med. Wkly 147, w14514 (2017).","journal-title":"Swiss Med. Wkly"},{"key":"985_CR15","doi-asserted-by":"publisher","first-page":"F965","DOI":"10.1152\/ajprenal.00085.2003","volume":"285","author":"MA Cadnapaphornchai","year":"2003","unstructured":"Cadnapaphornchai, M. A. et al. Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am. J. Physiol. Ren. Physiol. 285, F965\u2013F971 (2003).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.me.39.020188.002233","volume":"39","author":"GL Robertson","year":"1988","unstructured":"Robertson, G. L. Differential diagnosis of polyuria. Annu. Rev. Med. 39, 425\u2013442 (1988).","journal-title":"Annu. Rev. Med."},{"key":"985_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","volume":"17","author":"JG Verbalis","year":"2003","unstructured":"Verbalis, J. G. Disorders of body water homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 17, 471\u2013503 (2003).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"985_CR18","first-page":"853","volume":"65","author":"CJ Thompson","year":"1987","unstructured":"Thompson, C. J. & Baylis, P. H. Thirst in diabetes insipidus: clinical relevance of quantitative assessment. Q. J. Med. 65, 853\u2013862 (1987).","journal-title":"Q. J. Med."},{"key":"985_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/cen.13384","volume":"87","author":"CO Sailer","year":"2017","unstructured":"Sailer, C. O. et al. Characteristics and outcomes of patients with profound hyponatraemia due to primary polydipsia. Clin. Endocrinol. 87, 492\u2013499 (2017).","journal-title":"Clin. Endocrinol."},{"key":"985_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/02841859909177729","volume":"40","author":"A Arslan","year":"1999","unstructured":"Arslan, A., Karaarslan, E. & Din\u00e7er, A. High intensity signal of the posterior pituitary. A study with horizontal direction of frequency-encoding and fat suppression MR techniques. Acta Radiol. 40, 142\u2013145 (1999).","journal-title":"Acta Radiol."},{"key":"985_CR21","first-page":"1273","volume":"13","author":"AM Moses","year":"1992","unstructured":"Moses, A. M., Clayton, B. & Hochhauser, L. Use of T1-weighted MR imaging to differentiate between primary polydipsia and central diabetes insipidus. Am. J. Neuroradiol. 13, 1273\u20131277 (1992).","journal-title":"Am. J. Neuroradiol."},{"key":"985_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11102-018-0885-3","volume":"21","author":"V Klyn","year":"2018","unstructured":"Klyn, V. et al. Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3\u2009T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences. Pituitary 21, 379\u2013383 (2018).","journal-title":"Pituitary"},{"key":"985_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM200010053431403","volume":"343","author":"M Maghnie","year":"2000","unstructured":"Maghnie, M. et al. Central diabetes insipidus in children and young adults. N. Engl. J. Med. 343, 998\u20131007 (2000).","journal-title":"N. Engl. J. Med."},{"key":"985_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1365-2265.2011.04270.x","volume":"76","author":"M Hannon","year":"2011","unstructured":"Hannon, M. et al. Anterior hypopituitarism is rare and autoimmune disease is common in adults with idiopathic central diabetes insipidus. Clin. Endocrinol. 76, 725\u2013728 (2011).","journal-title":"Clin. Endocrinol."},{"key":"985_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000442327","volume":"45","author":"JF Bonneville","year":"2016","unstructured":"Bonneville, J. F. Magnetic resonance imaging of pituitary tumors. Front. Horm. Res. 45, 97\u2013120 (2016).","journal-title":"Front. Horm. Res."},{"key":"985_CR26","first-page":"1954","volume":"84","author":"J Leger","year":"1999","unstructured":"Leger, J., Velasquez, A., Garel, C., Hassan, M. & Czernichow, P. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J. Clin. Endocrinol. Metab. 84, 1954\u20131960 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/BF01721052","volume":"59","author":"LH Block","year":"1981","unstructured":"Block, L. H., Furrer, J., Locher, R. A., Siegenthaler, W. & Vetter, W. Changes in tissue sensitivity to vasopressin in hereditary hypothalamic diabetes insipidus. Klin. Wochenschr. 59, 831\u2013836 (1981).","journal-title":"Klin. Wochenschr."},{"key":"985_CR28","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2012-1981","volume":"97","author":"W Fenske","year":"2012","unstructured":"Fenske, W. & Allolio, B. Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J. Clin. Endocrinol. Metab. 97, 3426\u20133437 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1210\/jc.2010-2345","volume":"96","author":"W Fenske","year":"2011","unstructured":"Fenske, W. et al. Copeptin in the differential diagnosis of the polydipsia\u2013polyuria syndrome \u2014 revisiting the direct and indirect water deprivation tests. J. Clin. Endocrinol. Metab. 96, 1506\u20131515 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJM198112243052601","volume":"305","author":"RL Zerbe","year":"1981","unstructured":"Zerbe, R. L. & Robertson, G. L. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N. Engl. J. Med. 305, 1539\u20131546 (1981).","journal-title":"N. Engl. J. Med."},{"key":"985_CR31","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1172\/JCI107423","volume":"52","author":"GL Robertson","year":"1973","unstructured":"Robertson, G. L., Mahr, E. A., Athar, S. & Sinha, T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52, 2340\u20132352 (1973).","journal-title":"J. Clin. Invest."},{"key":"985_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler, N. G., Struck, J., Alonso, C. & Bergmann, A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112\u2013119 (2006).","journal-title":"Clin. Chem."},{"key":"985_CR33","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1172\/JCI105040","volume":"43","author":"JW Czaczkes","year":"1964","unstructured":"Czaczkes, J. W. & Kleeman, C. R. The effect of various states of hydration and the plasma concentration on the turnover of antidiuretic hormone in mammals. J. Clin. Invest. 43, 1649\u20131658 (1964).","journal-title":"J. Clin. Invest."},{"key":"985_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","volume":"28","author":"DA Holwerda","year":"1972","unstructured":"Holwerda, D. A. A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur. J. Biochem. FEBS 28, 334\u2013339 (1972).","journal-title":"Eur. J. Biochem. FEBS"},{"key":"985_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1399-3011.1986.tb01827.x","volume":"27","author":"B Levy","year":"1986","unstructured":"Levy, B., Chauvet, M. T., Chauvet, J. & Acher, R. Ontogeny of bovine neurohypophysial hormone precursors. II. Foetal copeptin, the third domain of the vasopressin precursor. Int. J. Pept. Protein Res. 27, 320\u2013324 (1986).","journal-title":"Int. J. Pept. Protein Res."},{"key":"985_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1210\/jc.2010-2499","volume":"96","author":"S Balanescu","year":"2011","unstructured":"Balanescu, S. et al. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J. Clin. Endocrinol. Metab. 96, 1046\u20131052 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89505-9","volume":"11","author":"CO Sailer","year":"2021","unstructured":"Sailer, C. O. et al. Validity of different copeptin assays in the differential diagnosis of the polyuria\u2013polydipsia syndrome. Sci. Rep. 11, 10104 (2021).","journal-title":"Sci. Rep."},{"key":"985_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","volume":"28","author":"NG Morgenthaler","year":"2007","unstructured":"Morgenthaler, N. G. et al. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28, 219\u2013226 (2007).","journal-title":"Shock"},{"key":"985_CR39","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1210\/jc.2007-0232","volume":"92","author":"G Szinnai","year":"2007","unstructured":"Szinnai, G. et al. Changes in plasma copeptin, the C-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J. Clin. Endocrinol. Metab. 92, 3973\u20133978 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR40","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.21783","volume":"66","author":"M Katan","year":"2009","unstructured":"Katan, M. et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann. Neurol. 66, 799\u2013808 (2009).","journal-title":"Ann. Neurol."},{"key":"985_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","volume":"54","author":"T Reichlin","year":"2009","unstructured":"Reichlin, T. et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Cardiol. 54, 60\u201368 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"985_CR42","first-page":"w13101","volume":"140","author":"M Katan","year":"2010","unstructured":"Katan, M. & Christ-Crain, M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med. Wkly 140, w13101 (2010).","journal-title":"Swiss Med. Wkly"},{"key":"985_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/10253890.2014.993966","volume":"18","author":"SA Urwyler","year":"2015","unstructured":"Urwyler, S. A., Schuetz, P., Sailer, C. & Christ-Crain, M. Copeptin as a stress marker prior and after a written examination \u2014 the CoEXAM study. Stress 18, 134\u2013137 (2015).","journal-title":"Stress"},{"key":"985_CR44","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/cen.14417","volume":"94","author":"E Brooks","year":"2021","unstructured":"Brooks, E. et al. Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals. Clin. Endocrinol. 94, 820\u2013826 (2021).","journal-title":"Clin. Endocrinol."},{"key":"985_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1210\/jc.2017-01891","volume":"103","author":"WK Fenske","year":"2018","unstructured":"Fenske, W. K. et al. Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers. J. Clin. Endocrinol. Metab. 103, 505\u2013513 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR46","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1210\/jc.2014-4507","volume":"100","author":"K Timper","year":"2015","unstructured":"Timper, K. et al. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria\u2013polydipsia syndrome: a prospective multicenter study. J. Clin. Endocrinol. Metab. 100, 2268\u20132274 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR47","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM196906262802603","volume":"280","author":"TJ Merimee","year":"1969","unstructured":"Merimee, T. J., Rabinowtitz, D. & Fineberg, S. E. Arginine-initiated release of human growth hormone. Factors modifying the response in normal man. N. Engl. J. Med. 280, 1434\u20131438 (1969).","journal-title":"N. Engl. J. Med."},{"key":"985_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0278-5846(85)90031-4","volume":"9","author":"NP Nair","year":"1985","unstructured":"Nair, N. P. et al. Effect of normal aging on the prolactin response to graded doses of sulpiride and to arginine. Prog. Neuropsychopharmacol. Biol. Psychiatry 9, 633\u2013637 (1985).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"985_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1530\/EJE-22-0033","volume":"187","author":"C Atila","year":"2022","unstructured":"Atila, C. et al. Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study. Eur. J. Endocrinol. 187, 65\u201374 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"985_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11102-021-01132-9","volume":"24","author":"SA Urwyler","year":"2021","unstructured":"Urwyler, S. A. et al. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary 24, 555\u2013563 (2021).","journal-title":"Pituitary"},{"key":"985_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EJE-14-0719","volume":"172","author":"LA Behan","year":"2015","unstructured":"Behan, L. A. et al. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study. Eur. J. Endocrinol. 172, 243\u2013250 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"985_CR52","first-page":"206","volume":"56","author":"AN Pedersen","year":"2023","unstructured":"Pedersen, A. N., Krogh, J., Andreassen, M. & Rasmussen, A. K. Desmopressin dose requirements in adults with congenital and acquired central diabetes insipidus. Horm. Metab. Res. 56, 206\u2013213 (2023).","journal-title":"Horm. Metab. Res."},{"key":"985_CR53","doi-asserted-by":"publisher","first-page":"G8","DOI":"10.1530\/EC-18-0154","volume":"7","author":"SE Baldeweg","year":"2018","unstructured":"Baldeweg, S. E. et al. Society for Endocrinology Clinical Guidance: inpatient management of cranial diabetes insipidus. Endocr. Connect. 7, G8\u2013G11 (2018).","journal-title":"Endocr. Connect."},{"key":"985_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7326\/0003-4819-103-2-228","volume":"103","author":"DW Richardson","year":"1985","unstructured":"Richardson, D. W. & Robinson, A. G. Desmopressin. Ann. Intern. Med. 103, 228\u2013239 (1985).","journal-title":"Ann. Intern. Med."},{"key":"985_CR55","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","volume":"29","author":"SG Achinger","year":"2014","unstructured":"Achinger, S. G., Arieff, A. I., Kalantar-Zadeh, K. & Ayus, J. C. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series. Nephrol. Dial. Transplant. 29, 2310\u20132315 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"985_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-physiol-020518-114556","volume":"81","author":"DG Bichet","year":"2019","unstructured":"Bichet, D. G. Regulation of thirst and vasopressin release. Annu. Rev. Physiol. 81, 359\u2013373 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"985_CR57","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.3390\/jcm11195810","volume":"11","author":"GH Kim","year":"2022","unstructured":"Kim, G. H. Pathophysiology of drug-induced hyponatremia. J. Clin. Med. 11, 5810 (2022).","journal-title":"J. Clin. Med."},{"key":"985_CR58","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1210\/clinem\/dgac381","volume":"107","author":"M Tomkins","year":"2022","unstructured":"Tomkins, M., Lawless, S., Martin-Grace, J., Sherlock, M. & Thompson, C. J. Diagnosis and management of central diabetes insipidus in adults. J. Clin. Endocrinol. Metab. 107, 2701\u20132715 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02191-2","volume":"17","author":"H Teare","year":"2022","unstructured":"Teare, H. et al. Challenges and improvement needs in the care of patients with central diabetes insipidus. Orphanet. J. Rare Dis. 17, 58 (2022).","journal-title":"Orphanet. J. Rare Dis."},{"key":"985_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/joim.13261","volume":"290","author":"M Christ-Crain","year":"2021","unstructured":"Christ-Crain, M., Winzeler, B. & Refardt, J. Diagnosis and management of diabetes insipidus for the internist: an update. J. Intern. Med. 290, 73\u201387 (2021).","journal-title":"J. Intern. Med."},{"key":"985_CR61","doi-asserted-by":"crossref","unstructured":"Melmed, S., Polonsky, K. S., Larsen, P. R. & Kronenberg, H. M. Williams Textbook of Endocrinology 14th edn (Elsevier, 2019).","DOI":"10.33029\/9704-4951-6-PEND-1-848"},{"key":"985_CR62","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1507\/endocrj.50.437","volume":"50","author":"I Fukuda","year":"2003","unstructured":"Fukuda, I., Hizuka, N. & Takano, K. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. Endocr. J. 50, 437\u2013443 (2003).","journal-title":"Endocr. J."},{"key":"985_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1507\/endocrj.EJ14-0368","volume":"62","author":"Y Kataoka","year":"2015","unstructured":"Kataoka, Y., Nishida, S., Hirakawa, A., Oiso, Y. & Arima, H. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus. Endocr. J. 62, 195\u2013200 (2015).","journal-title":"Endocr. J."},{"key":"985_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12549","author":"F Althammer","year":"2017","unstructured":"Althammer, F. & Grinevich, V. Diversity of oxytocin neurons: beyond magno- and parvocellular cell types? J. Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.12549 (2017).","journal-title":"J. Neuroendocrinol."},{"key":"985_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-820107-7.00003-3","volume":"180","author":"F Althammer","year":"2021","unstructured":"Althammer, F., Eliava, M. & Grinevich, V. Central and peripheral release of oxytocin: relevance of neuroendocrine and neurotransmitter actions for physiology and behavior. Handb. Clin. Neurol. 180, 25\u201344 (2021).","journal-title":"Handb. Clin. Neurol."},{"key":"985_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.ne.06.030183.001413","volume":"6","author":"LW Swanson","year":"1983","unstructured":"Swanson, L. W. & Sawchenko, P. E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6, 269\u2013324 (1983).","journal-title":"Annu. Rev. Neurosci."},{"key":"985_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuron.2020.10.032","volume":"109","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain. Neuron 109, 331\u2013346.e7 (2021).","journal-title":"Neuron"},{"key":"985_CR68","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.neuron.2011.11.030","volume":"73","author":"HS Knobloch","year":"2012","unstructured":"Knobloch, H. S. et al. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73, 553\u2013566 (2012).","journal-title":"Neuron"},{"key":"985_CR69","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1523\/JNEUROSCI.2409-15.2016","volume":"36","author":"M Mitre","year":"2016","unstructured":"Mitre, M. et al. A distributed network for social cognition enriched for oxytocin receptors. J. Neurosci. 36, 2517\u20132535 (2016).","journal-title":"J. Neurosci."},{"key":"985_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23064-5","volume":"12","author":"VEM Oliveira","year":"2021","unstructured":"Oliveira, V. E. M. et al. Oxytocin and vasopressin within the ventral and dorsal lateral septum modulate aggression in female rats. Nat. Commun. 12, 2900 (2021).","journal-title":"Nat. Commun."},{"key":"985_CR71","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn3044","volume":"12","author":"A Meyer-Lindenberg","year":"2011","unstructured":"Meyer-Lindenberg, A., Domes, G., Kirsch, P. & Heinrichs, M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12, 524\u2013538 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"985_CR72","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cub.2018.02.044","volume":"28","author":"R Menon","year":"2018","unstructured":"Menon, R. et al. Oxytocin signaling in the lateral septum prevents social fear during lactation. Curr. Biol. 28, 1066\u20131078.e66 (2018).","journal-title":"Curr. Biol."},{"key":"985_CR73","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.cub.2019.04.070","volume":"29","author":"V Ferretti","year":"2019","unstructured":"Ferretti, V. et al. Oxytocin signaling in the central amygdala modulates emotion discrimination in mice. Curr. Biol. 29, 1938\u20131953.e6 (2019).","journal-title":"Curr. Biol."},{"key":"985_CR74","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1152\/ajpregu.00604.2003","volume":"287","author":"JE Blevins","year":"2004","unstructured":"Blevins, J. E., Schwartz, M. W. & Baskin, D. G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R87\u2013R96 (2004).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"985_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-8993(86)91485-X","volume":"398","author":"MR Melis","year":"1986","unstructured":"Melis, M. R., Argiolas, A. & Gessa, G. L. Oxytocin-induced penile erection and yawning: site of action in the brain. Brain Res. 398, 259\u2013265 (1986).","journal-title":"Brain Res."},{"key":"985_CR76","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0079-6123(02)39024-1","volume":"139","author":"M Petersson","year":"2002","unstructured":"Petersson, M. Cardiovascular effects of oxytocin. Prog. Brain Res. 139, 281\u2013288 (2002).","journal-title":"Prog. Brain Res."},{"key":"985_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fendo.2013.00035","volume":"4","author":"N Sabatier","year":"2013","unstructured":"Sabatier, N., Leng, G. & Menzies, J. Oxytocin, feeding, and satiety. Front. Endocrinol. 4, 35 (2013).","journal-title":"Front. Endocrinol."},{"key":"985_CR78","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/AJP.0b013e31829f57df","volume":"30","author":"JA Rash","year":"2014","unstructured":"Rash, J. A., Aguirre-Camacho, A. & Campbell, T. S. Oxytocin and pain: a systematic review and synthesis of findings. Clin. J. Pain 30, 453\u2013462 (2014).","journal-title":"Clin. J. Pain"},{"key":"985_CR79","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.neuron.2016.01.041","volume":"89","author":"M Eliava","year":"2016","unstructured":"Eliava, M. et al. A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron 89, 1291\u20131304 (2016).","journal-title":"Neuron"},{"key":"985_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuron.2019.04.029","volume":"103","author":"MT Hasan","year":"2019","unstructured":"Hasan, M. T. et al. A fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103, 133\u2013146.e8 (2019).","journal-title":"Neuron"},{"key":"985_CR81","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41593-020-0674-y","volume":"23","author":"Y Tang","year":"2020","unstructured":"Tang, Y. et al. Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. Nat. Neurosci. 23, 1125\u20131137 (2020).","journal-title":"Nat. Neurosci."},{"key":"985_CR82","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1210\/en.2002-0197","volume":"144","author":"RC Mantella","year":"2003","unstructured":"Mantella, R. C., Vollmer, R. R., Li, X. & Amico, J. A. Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 144, 2291\u20132296 (2003).","journal-title":"Endocrinology"},{"key":"985_CR83","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/77040","volume":"25","author":"JN Ferguson","year":"2000","unstructured":"Ferguson, J. N. et al. Social amnesia in mice lacking the oxytocin gene. Nat. Genet. 25, 284\u2013288 (2000).","journal-title":"Nat. Genet."},{"key":"985_CR84","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/eje.1.02176","volume":"155","author":"M Koltowska-H\u00e4ggstr\u00f6m","year":"2006","unstructured":"Koltowska-H\u00e4ggstr\u00f6m, M. et al. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life. Eur. J. Endocrinol. 155, 109\u2013119 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"985_CR85","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ecl.2014.10.013","volume":"44","author":"I Crespo","year":"2015","unstructured":"Crespo, I., Valassi, E., Santos, A. & Webb, S. M. Health-related quality of life in pituitary diseases. Endocrinol. Metab. Clin. North Am. 44, 161\u2013170 (2015).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"985_CR86","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12020-015-0637-3","volume":"51","author":"A Nozaki","year":"2016","unstructured":"Nozaki, A. et al. Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire. Endocrine 51, 140\u2013147 (2016).","journal-title":"Endocrine"},{"key":"985_CR87","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","volume":"62","author":"N Karavitaki","year":"2005","unstructured":"Karavitaki, N. et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin. Endocrinol. 62, 397\u2013409 (2005).","journal-title":"Clin. Endocrinol."},{"key":"985_CR88","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/er.2006-0002","volume":"27","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki, N., Cudlip, S., Adams, C. B. & Wass, J. A. Craniopharyngiomas. Endocr. Rev. 27, 371\u2013397 (2006).","journal-title":"Endocr. Rev."},{"key":"985_CR89","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EJE-17-0044","volume":"176","author":"M Wijnen","year":"2017","unstructured":"Wijnen, M. et al. Very long-term sequelae of craniopharyngioma. Eur. J. Endocrinol. 176, 755\u2013767 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"985_CR90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","volume":"62","author":"AM Pereira","year":"2005","unstructured":"Pereira, A. M. et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin. Endocrinol. 62, 197\u2013204 (2005).","journal-title":"Clin. Endocrinol."},{"key":"985_CR91","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/cen.13909","volume":"90","author":"R Bhargava","year":"2019","unstructured":"Bhargava, R., Daughters, K. L. & Rees, A. Oxytocin therapy in hypopituitarism: challenges and opportunities. Clin. Endocrinol. 90, 257\u2013264 (2019).","journal-title":"Clin. Endocrinol."},{"key":"985_CR92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11102-019-00936-0","volume":"22","author":"Y Eisenberg","year":"2019","unstructured":"Eisenberg, Y. et al. Oxytocin alterations and neurocognitive domains in patients with hypopituitarism. Pituitary 22, 105\u2013112 (2019).","journal-title":"Pituitary"},{"key":"985_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psyneuen.2017.11.006","volume":"88","author":"D Gebert","year":"2018","unstructured":"Gebert, D. et al. De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function. Psychoneuroendocrinology 88, 61\u201369 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"985_CR94","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12020-017-1332-3","volume":"57","author":"K Daughters","year":"2017","unstructured":"Daughters, K., Manstead, A. S. R. & Rees, D. A. Hypopituitarism is associated with lower oxytocin concentrations and reduced empathic ability. Endocrine 57, 166\u2013174 (2017).","journal-title":"Endocrine"},{"key":"985_CR95","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12020-016-1084-5","volume":"54","author":"AM Daubenb\u00fcchel","year":"2016","unstructured":"Daubenb\u00fcchel, A. M. et al. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine 54, 524\u2013531 (2016).","journal-title":"Endocrine"},{"key":"985_CR96","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1210\/jc.2018-02608","volume":"104","author":"A Aulinas","year":"2019","unstructured":"Aulinas, A. et al. Low plasma oxytocin levels and increased psychopathology in hypopituitary men with diabetes insipidus. J. Clin. Endocrinol. Metab. 104, 3181\u20133191 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"985_CR97","doi-asserted-by":"publisher","unstructured":"Leng, G. & Sabatier, N. Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers. J. Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.12413 (2016).","DOI":"10.1111\/jne.12413"},{"key":"985_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neubiorev.2017.04.017","volume":"78","author":"M Valstad","year":"2017","unstructured":"Valstad, M. et al. The correlation between central and peripheral oxytocin concentrations: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 78, 117\u2013124 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"985_CR99","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000126185","volume":"55","author":"P Chiodera","year":"1992","unstructured":"Chiodera, P. et al. Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood\u2013brain barrier. Neuroendocrinology 55, 655\u2013659 (1992).","journal-title":"Neuroendocrinology"},{"key":"985_CR100","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/EJE-21-0346","volume":"185","author":"CO Sailer","year":"2021","unstructured":"Sailer, C. O. et al. Oxytocin levels in response to pituitary provocation tests in healthy volunteers. Eur. J. Endocrinol. 185, 355\u2013364 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"985_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12842","volume":"32","author":"ML Brandi","year":"2020","unstructured":"Brandi, M. L., Gebert, D., Kopczak, A., Auer, M. K. & Schilbach, L. Oxytocin release deficit and social cognition in craniopharyngioma patients. J. Neuroendocrinol. 32, e12842 (2020).","journal-title":"J. Neuroendocrinol."},{"key":"985_CR102","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","volume":"45","author":"F Holze","year":"2020","unstructured":"Holze, F. et al. Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects. Neuropsychopharmacology 45, 462\u2013471 (2020).","journal-title":"Neuropsychopharmacology"},{"key":"985_CR103","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/npp.2014.12","volume":"39","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S. & de Wit, H. Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology 39, 1654\u20131663 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"985_CR104","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00213-017-4650-5","volume":"235","author":"PC Dolder","year":"2018","unstructured":"Dolder, P. C., M\u00fcller, F., Schmid, Y., Borgwardt, S. J. & Liechti, M. E. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology 235, 467\u2013479 (2018).","journal-title":"Psychopharmacology"},{"key":"985_CR105","doi-asserted-by":"publisher","first-page":"906639","DOI":"10.3389\/fphar.2022.906639","volume":"13","author":"P Vizeli","year":"2022","unstructured":"Vizeli, P. et al. Effects of 3,4-methylenedioxymethamphetamine on conditioned fear extinction and retention in a crossover study in healthy subjects. Front. Pharmacol. 13, 906639 (2022).","journal-title":"Front. Pharmacol."},{"key":"985_CR106","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41574-023-00870-z","volume":"19","author":"JG Verbalis","year":"2023","unstructured":"Verbalis, J. G. Oxytocin deficiency \u2014 a \u2018new\u2019 human disorder? Nat. Rev. Endocrinol. 19, 505\u2013506 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"985_CR107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/164_2018_113","volume":"252","author":"LD Simmler","year":"2018","unstructured":"Simmler, L. D. & Liechti, M. E. Pharmacology of MDMA- and amphetamine-like new psychoactive substances. Handb. Exp. Pharmacol. 252, 143\u2013164 (2018).","journal-title":"Handb. Exp. Pharmacol."},{"key":"985_CR108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2011.06.011","volume":"86","author":"GE Hunt","year":"2011","unstructured":"Hunt, G. E., McGregor, I. S., Cornish, J. L. & Callaghan, P. D. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Res. Bull. 86, 65\u201373 (2011).","journal-title":"Brain Res. Bull."},{"key":"985_CR109","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.psyneuen.2011.03.011","volume":"36","author":"L Schulze","year":"2011","unstructured":"Schulze, L. et al. Oxytocin increases recognition of masked emotional faces. Psychoneuroendocrinology 36, 1378\u20131382 (2011).","journal-title":"Psychoneuroendocrinology"},{"key":"985_CR110","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.psyneuen.2011.07.015","volume":"37","author":"A Lischke","year":"2012","unstructured":"Lischke, A. et al. Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected. Psychoneuroendocrinology 37, 475\u2013481 (2012).","journal-title":"Psychoneuroendocrinology"},{"key":"985_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0658-4","volume":"9","author":"G Domes","year":"2019","unstructured":"Domes, G. et al. Effects of intranasal oxytocin administration on empathy and approach motivation in women with borderline personality disorder: a randomized controlled trial. Transl. Psychiatry 9, 328 (2019).","journal-title":"Transl. Psychiatry"},{"key":"985_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08503-8","volume":"10","author":"DS Quintana","year":"2019","unstructured":"Quintana, D. S. et al. Oxytocin pathway gene networks in the human brain. Nat. Commun. 10, 668 (2019).","journal-title":"Nat. Commun."},{"key":"985_CR113","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/scan\/nsx085","volume":"12","author":"D Wang","year":"2017","unstructured":"Wang, D., Yan, X., Li, M. & Ma, Y. Neural substrates underlying the effects of oxytocin: a quantitative meta-analysis of pharmaco-imaging studies. Soc. Cogn. Affect Neurosci. 12, 1565\u20131573 (2017).","journal-title":"Soc. Cogn. Affect Neurosci."},{"key":"985_CR114","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.psyneuen.2018.05.031","volume":"96","author":"SA Grace","year":"2018","unstructured":"Grace, S. A., Rossell, S. L., Heinrichs, M., Kordsachia, C. & Labuschagne, I. Oxytocin and brain activity in humans: a systematic review and coordinate-based meta-analysis of functional MRI studies. Psychoneuroendocrinology 96, 6\u201324 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"985_CR115","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","volume":"62","author":"G Domes","year":"2007","unstructured":"Domes, G. et al. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 62, 1187\u20131190 (2007).","journal-title":"Biol. Psychiatry"},{"key":"985_CR116","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1073\/pnas.1208852109","volume":"109","author":"N Striepens","year":"2012","unstructured":"Striepens, N. et al. Oxytocin facilitates protective responses to aversive social stimuli in males. Proc. Natl Acad. Sci. USA 109, 18144\u201318149 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"985_CR117","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.biopsych.2015.05.003","volume":"79","author":"G Leng","year":"2016","unstructured":"Leng, G. & Ludwig, M. Intranasal oxytocin: myths and delusions. Biol. Psychiatry 79, 243\u2013250 (2016).","journal-title":"Biol. Psychiatry"},{"key":"985_CR118","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.yhbeh.2011.12.003","volume":"61","author":"PS Churchland","year":"2012","unstructured":"Churchland, P. S. & Winkielman, P. Modulating social behavior with oxytocin: how does it work? What does it mean. Horm. Behav. 61, 392\u2013399 (2012).","journal-title":"Horm. Behav."},{"key":"985_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15942-1","volume":"11","author":"MR Lee","year":"2020","unstructured":"Lee, M. R. et al. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nat. Commun. 11, 2783 (2020).","journal-title":"Nat. Commun."},{"key":"985_CR120","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/mp.2017.27","volume":"23","author":"MR Lee","year":"2018","unstructured":"Lee, M. R. et al. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol. Psychiatry 23, 115\u2013122 (2018).","journal-title":"Mol. Psychiatry"},{"key":"985_CR121","doi-asserted-by":"publisher","first-page":"104324","DOI":"10.1016\/j.phrs.2019.104324","volume":"146","author":"AS Smith","year":"2019","unstructured":"Smith, A. S., Korgan, A. C. & Young, W. S. Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice. Pharmacol. Res. 146, 104324 (2019).","journal-title":"Pharmacol. Res."},{"key":"985_CR122","doi-asserted-by":"publisher","first-page":"104325","DOI":"10.1016\/j.phrs.2019.104325","volume":"146","author":"MT Bowen","year":"2019","unstructured":"Bowen, M. T. Does peripherally administered oxytocin enter the brain? Compelling new evidence in a long-running debate. Pharmacol. Res. 146, 104325 (2019).","journal-title":"Pharmacol. Res."},{"key":"985_CR123","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1515\/jpem-2015-0445","volume":"29","author":"N Cook","year":"2016","unstructured":"Cook, N., Miller, J. & Hart, J. Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma. J. Pediatr. Endocrinol. Metab. 29, 995\u20131000 (2016).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"985_CR124","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12020-017-1257-x","volume":"56","author":"A Hoffmann","year":"2017","unstructured":"Hoffmann, A. et al. First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma. Endocrine 56, 175\u2013185 (2017).","journal-title":"Endocrine"},{"key":"985_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235806","volume":"15","author":"K Uvn\u00e4s Moberg","year":"2020","unstructured":"Uvn\u00e4s Moberg, K. et al. Maternal plasma levels of oxytocin during breastfeeding \u2014 a systematic review. PLoS ONE 15, e0235806 (2020).","journal-title":"PLoS ONE"},{"key":"985_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2365-9","volume":"19","author":"K Uvn\u00e4s-Moberg","year":"2019","unstructured":"Uvn\u00e4s-Moberg, K. et al. Maternal plasma levels of oxytocin during physiological childbirth \u2014 a systematic review with implications for uterine contractions and central actions of oxytocin. BMC Pregnancy Childb. 19, 285 (2019).","journal-title":"BMC Pregnancy Childb."},{"key":"985_CR127","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0015-0282(01)03198-3","volume":"77","author":"J Volz","year":"2002","unstructured":"Volz, J., Heinrich, U. & Volz-K\u00f6ster, S. Conception and spontaneous delivery after total hypophysectomy. Fertil. Steril. 77, 624\u2013625 (2002).","journal-title":"Fertil. Steril."},{"key":"985_CR128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejogrb.2015.11.028","volume":"197","author":"S Shinar","year":"2016","unstructured":"Shinar, S., Many, A. & Maslovitz, S. Questioning the role of pituitary oxytocin in parturition: spontaneous onset of labor in women with panhypopituitarism \u2014 a case series. Eur. J. Obstet. Gynecol. Reprod. Biol. 197, 83\u201385 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"985_CR129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/089033449300900129","volume":"9","author":"J De Coopman","year":"1993","unstructured":"De Coopman, J. Breastfeeding after pituitary resection: support for a theory of autocrine control of milk supply? J. Hum. Lact. 9, 35\u201340 (1993).","journal-title":"J. Hum. Lact."},{"key":"985_CR130","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1365-2826.1996.05266.x","volume":"8","author":"WS Young III","year":"1996","unstructured":"Young, W. S. III et al. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J. Neuroendocrinol. 8, 847\u2013853 (1996).","journal-title":"J. Neuroendocrinol."},{"key":"985_CR131","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11102-021-01196-7","volume":"25","author":"A Aulinas","year":"2022","unstructured":"Aulinas, A. et al. Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome. Pituitary 25, 275\u2013284 (2022).","journal-title":"Pituitary"},{"key":"985_CR132","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000506639","volume":"111","author":"P Sowithayasakul","year":"2021","unstructured":"Sowithayasakul, P., Boekhoff, S., Bison, B. & M\u00fcller, H. L. Pregnancies after childhood craniopharyngioma: results of KRANIOPHARYNGEOM 2000\/2007 and review of the literature. Neuroendocrinology 111, 16\u201326 (2021).","journal-title":"Neuroendocrinology"},{"key":"985_CR133","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1210\/js.2017-00005","volume":"1","author":"FA Correa","year":"2017","unstructured":"Correa, F. A. et al. Successful pregnancies after adequate hormonal replacement in patients with combined pituitary hormone deficiencies. J. Endocr. Soc. 1, 1322\u20131330 (2017).","journal-title":"J. Endocr. Soc."},{"key":"985_CR134","unstructured":"Bichet, D. G. & Verbalis, J. G. Arginine vasopressin deficiency (central diabetes insipidus): etiology, clinical manifestations, and postdiagnostic evaluation. UpToDate. Wolters Kluwer. https:\/\/www.uptodate.com\/contents\/arginine-vasopressin-deficiency-central-diabetes-insipidus-etiology-clinical-manifestations-and-postdiagnostic-evaluation (2023)."}],"updated-by":[{"DOI":"10.1038\/s41574-024-00998-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000}}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00985-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:02:45Z","timestamp":1720947765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00985-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":134,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-00985-x","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"26 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-024-00998-6","URL":"https:\/\/doi.org\/10.1038\/s41574-024-00998-6","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A., J.R. and M.C.-C. received occasional kits for copeptin measurements from Thermo Fisher AG, the manufacturer of the copeptin assay.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}